Home/Saccharo/Sherry (Sheryl) Martin-Moe, PhD
S(

Sherry (Sheryl) Martin-Moe, PhD

CEO, President, Founder

Saccharo

Therapeutic Areas

Saccharo Pipeline

DrugIndicationPhase
SAC-253Oncology (broad potential)Preclinical